Medexus Pharmaceuticals Inc
TSX:MDP
Medexus Pharmaceuticals Inc
Depreciation & Amortization
Medexus Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medexus Pharmaceuticals Inc
TSX:MDP
|
Depreciation & Amortization
-$259k
|
CAGR 3-Years
27%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Canopy Growth Corp
TSX:WEED
|
Depreciation & Amortization
-CA$31.2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Depreciation & Amortization
-$4.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Depreciation & Amortization
-$215m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Depreciation & Amortization
-$9.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Medexus Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
-259k
USD
Based on the financial report for Dec 31, 2023, Medexus Pharmaceuticals Inc's Depreciation & Amortization amounts to -259k USD.
What is Medexus Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-15%
Over the last year, the Depreciation & Amortization growth was 31%. The average annual Depreciation & Amortization growth rates for Medexus Pharmaceuticals Inc have been 27% over the past three years , -15% over the past five years .